摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2-Methylsulfonylethyl 2-(6-methoxynaphthalen-2-yl)propanoate

中文名称
——
中文别名
——
英文名称
2-Methylsulfonylethyl 2-(6-methoxynaphthalen-2-yl)propanoate
英文别名
——
2-Methylsulfonylethyl 2-(6-methoxynaphthalen-2-yl)propanoate化学式
CAS
——
化学式
C17H20O5S
mdl
——
分子量
336.4
InChiKey
JGBUBSOKFSVXKS-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    2.5
  • 重原子数:
    23
  • 可旋转键数:
    7
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.35
  • 拓扑面积:
    78
  • 氢给体数:
    0
  • 氢受体数:
    5

文献信息

  • COMPOSITIONS INCLUDING LEUKOTRIENE ANTAGONISTS AND NSAIDS AND METHODS OF USING THE SAME
    申请人:Fink Mitchell P.
    公开号:US20100221334A1
    公开(公告)日:2010-09-02
    Pharmaceutical compositions containing non-steroidal anti-inflammatory drugs (NSAIDs) and modified NSAIDs and leukotriene antagonists and methods for using such pharmaceutical compositions are provided herein. In a preffered embodiment naproxene 2-(methanesulfonyl)-ethyl ester is used in combination with Zileuton.
  • METHOD OF TREATING ARTHRITIS, PAIN OR INFLAMMATION WITH NAPROXEN 2(METHANESULFONYL)ETHYL ESTER AND A PROTON PUMP INHIBITOR
    申请人:Fink Mitchell P.
    公开号:US20100221336A1
    公开(公告)日:2010-09-02
    Embodiments of the present invention provide methods of treating pain, arthritis and inflammation comprising administering naproxen 2(methanesulfonyl)ethyl ester and a proton pump inhibitor. Further embodiments provide pharmaceutical compositions comprising naproxen 2(methanesulfonyl)ethyl ester and a proton pump inhibitor.
  • METHOD OF TREATING ARTHRITIS, PAIN OR INFLAMMATION WITH NAPROXEN 2(METHANESULFONYL)ETHYL ESTER AND AN H2 RECEPTOR ANTAGONIST
    申请人:Fink Mitchell P.
    公开号:US20100221337A1
    公开(公告)日:2010-09-02
    Embodiments of the present invention provide methods of treating pain, arthritis and inflammation comprising administering naproxen 2(methanesulfonyl)ethyl ester and an H2 receptor antagonist. Further embodiments provide pharmaceutical compositions comprising naproxen 2(methanesulfonyl)ethyl ester and an H2 receptor antagonist.
  • USRE41151E1
    申请人:——
    公开号:USRE41151E1
    公开(公告)日:2010-02-23
  • [EN] COMPOSITIONS INCLUDING LEUKOTRIENE ANTAGONISTS AND NSAIDS AND METHODS OF USING THE SAME<br/>[FR] COMPOSITIONS COMPRENANT DES ANTAGONISTES DES LEUCOTRIÈNES ET DES NSAID, ET LEURS MÉTHODES D'UTILISATION
    申请人:LOGIGAL THERAPEUTICS INC
    公开号:WO2009012425A2
    公开(公告)日:2009-01-22
    Pharmaceutical compositions containing non-steroidal anti-inflammatory drugs (NSAIDs) and modified NSAIDs and leukotriene antagonists and methods for using such pharmaceutical compositions are provided herein. In a preffered embodiment naproxene 2- (methanesulfonyl) -ethyl ester is used in combination with Zileuton.
查看更多